Hsu C, Haacke E, Heyn C, Kato K, Watkins T, Krings T
Neuroradiology. 2018; 61(1):13-15.
PMID: 30406271
PMC: 7003147.
DOI: 10.1007/s00234-018-2128-8.
Puri V, Gupta A, Chaudhry N, Saran R
Ann Indian Acad Neurol. 2015; 18(4):464-7.
PMID: 26713026
PMC: 4683893.
DOI: 10.4103/0972-2327.160088.
Sachdeva S, Gandhi R, Verma P, Kaur A, Kapoor R
J Clin Diagn Res. 2015; 9(8):VD01-VD03.
PMID: 26436026
PMC: 4576620.
DOI: 10.7860/JCDR/2015/13730.6271.
Ramcharan K, Ramesar A, Ramdath M, Teelucksingh J, Gosein M
Case Rep Neurol Med. 2014; 2014:850109.
PMID: 25045557
PMC: 4087279.
DOI: 10.1155/2014/850109.
Martinez-Alfaro M, Alcaraz-Contreras Y, Carabez-Trejo A, Leo-Amador G
Indian J Occup Environ Med. 2012; 15(3):87-92.
PMID: 22412283
PMC: 3299103.
DOI: 10.4103/0019-5278.93195.
Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.
Licata S, Renshaw P
Ann N Y Acad Sci. 2010; 1187:148-71.
PMID: 20201852
PMC: 3040110.
DOI: 10.1111/j.1749-6632.2009.05143.x.
Smaller gray matter volumes in frontal and parietal cortices of solvent abusers correlate with cognitive deficits.
Aydin K, Kircan S, Sarwar S, Okur O, Balaban E
AJNR Am J Neuroradiol. 2009; 30(10):1922-8.
PMID: 19643925
PMC: 7051300.
DOI: 10.3174/ajnr.A1728.
The oxidative and morphological effects of high concentration chronic toluene exposure on rat sciatic nerves.
Coskun O, Oter S, Korkmaz A, Armutcu F, Kanter M
Neurochem Res. 2005; 30(1):33-8.
PMID: 15756930
DOI: 10.1007/s11064-004-9683-6.
Cranial MR findings in chronic toluene abuse by inhalation.
Aydin K, Sencer S, Demir T, Ogel K, Tunaci A, Minareci O
AJNR Am J Neuroradiol. 2002; 23(7):1173-9.
PMID: 12169477
PMC: 8185739.
Childhood abuse and the use of inhalants: differences by degree of use.
Fendrich M, Mackesy-Amiti M, Wislar J, GOLDSTEIN P
Am J Public Health. 1997; 87(5):765-9.
PMID: 9184503
PMC: 1381047.
DOI: 10.2105/ajph.87.5.765.
The pathogenesis of multiple sclerosis. Additional considerations.
Poser C
J Neurol Sci. 1993; 115 Suppl:S3-15.
PMID: 7688036
PMC: 7130122.
DOI: 10.1016/0022-510x(93)90203-b.
MRI in chronic paint-thinner intoxication.
Ohnuma A, Kimura I, Saso S
Neuroradiology. 1995; 37(6):445-6.
PMID: 7477852
DOI: 10.1007/BF00600086.
Cranial MRI in chronic thinner intoxication.
Ashikaga R, Araki Y, Miura K, Ishida O
Neuroradiology. 1995; 37(6):443-4.
PMID: 7477851
DOI: 10.1007/BF00600085.
Progressive optic neuropathy and sensorineural hearing loss due to chronic glue sniffing.
Ehyai A, FREEMON F
J Neurol Neurosurg Psychiatry. 1983; 46(4):349-51.
PMID: 6842248
PMC: 1027359.
DOI: 10.1136/jnnp.46.4.349.
Persistent visual hallucinations secondary to chronic solvent encephalopathy: case report and review of the literature.
Channer K, Stanley S
J Neurol Neurosurg Psychiatry. 1983; 46(1):83-6.
PMID: 6842206
PMC: 1027270.
DOI: 10.1136/jnnp.46.1.83.
Solvent encephalopathy.
King M, Day R, Oliver J, Lush M, Watson J
Br Med J (Clin Res Ed). 1981; 283(6292):663-5.
PMID: 6790121
PMC: 1506769.
DOI: 10.1136/bmj.283.6292.663.
Progressive optic atrophy and sensorineural hearing loss due to chronic glue sniffing.
CAVANAGH J
J Neurol Neurosurg Psychiatry. 1983; 46(10):966.
PMID: 6644323
PMC: 1027616.
DOI: 10.1136/jnnp.46.10.966-a.
Clinical and electrophysiological findings in three patients with toluene dependency.
Toyonaga N, Adachi-Usami E, Yamazaki H
Doc Ophthalmol. 1989; 73(2):201-7.
PMID: 2638629
DOI: 10.1007/BF00155038.
An introduction to the clinical toxicology of volatile substances.
Flanagan R, Ruprah M, Meredith T, Ramsey J
Drug Saf. 1990; 5(5):359-83.
PMID: 2222869
DOI: 10.2165/00002018-199005050-00005.